| 1.25 0.49 (64.47%) | 07-06 14:05 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.83 |
1-year : | 2.14 |
| Resists | First : | 1.57 |
Second : | 1.83 |
| Pivot price | 0.83 |
|||
| Supports | First : | 1 |
Second : | 0.66 |
| MAs | MA(5) : | 0.89 |
MA(20) : | 0.85 |
| MA(100) : | 1.02 |
MA(250) : | 1.44  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 52.3 |
D(3) : | 48.9 |
| RSI | RSI(14): 75.9 |
|||
| 52-week | High : | 2.39 | Low : | 0.66 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LUCY ] has closed It is unclear right now based on current values. 228.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.8 - 0.81 | 0.81 - 0.81 |
| Low: | 0.75 - 0.76 | 0.76 - 0.76 |
| Close: | 0.75 - 0.76 | 0.76 - 0.77 |
Innovative Eyewear, Inc. specializes in the design and commercialization of intelligent eyewear, encompassing both eyeglasses and sunglasses. Central to its product line is Lucyd Lyte, a pair of smart glasses empowering users to engage with audio content, manage phone conversations, and activate smartphone functions hands-free through voice commands. Additionally, the company provides Vyrb, a social media application facilitating the vocal exchange of posts directly through Lucyd Lyte smart glasses. Its offerings reach consumers via diverse e-commerce platforms and traditional retail outlets. Established in 2019 and headquartered in North Miami, Florida, Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd., reflecting its close collaboration with the latter.
Mon, 06 Jul 2026
Lucy (LUCY) files Form 144: proposed resale of 1,860 common shares - Stock Titan
Mon, 06 Jul 2026
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Mon, 06 Jul 2026
LUCY Stock Pops As Innovative Eyewear Expands Prescription Smart Glasses - StocksToTrade
Mon, 06 Jul 2026
Innovative Eyewear posts 71% Q2 sales growth - grafa.com
Mon, 06 Jul 2026
LUCY Stock In Focus As Innovative Eyewear Expands Prescription Smart-Glasses Reach - timothysykes.com
Mon, 06 Jul 2026
Innovative Eyewear lands Canada order, U.S. retail test - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 7.5 (%) |
| Held by Institutions | 9 (%) |
| Shares Short | 19 (K) |
| Shares Short P.Month | 55 (K) |
| EPS | -1.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.33 |
| Profit Margin | -272.5 % |
| Operating Margin | -306.7 % |
| Return on Assets (ttm) | -64.4 % |
| Return on Equity (ttm) | -102.5 % |
| Qtrly Rev. Growth | 70.1 % |
| Gross Profit (p.s.) | 0.08 |
| Sales Per Share | 0.46 |
| EBITDA (p.s.) | -1.38 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.84 |
| PEG Ratio | 0 |
| Price to Book value | 0.97 |
| Price to Sales | 2.79 |
| Price to Cash Flow | -1.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|